Liu Yachao, Dong Yanliang, Liu Jiajin, Zhang Xiaojun, Lin Mu, Xu Baixuan
Department of Nuclear Medicine, Chinese PLA General Hospital, Beijing, China.
MR Collaboration, Diagnostic Imaging, Siemens Healthineers Ltd., Shanghai, China.
Prostate. 2021 Dec;81(16):1329-1336. doi: 10.1002/pros.24230. Epub 2021 Sep 13.
We aimed to compare the diagnostic performance of F-DCFPyL positron emission tomography (PET) and multiparameter magnetic resonance imaging (mp-MRI) in detecting transition zone (TZ) prostate cancer (PCa).
This retrospective study included 20 patients who underwent F-DCFPyL PET/MRI and 32 patients who underwent F-DCFPyL PET/CT and MRI from January 2019 to June 2020. All patients had TZ lesions and underwent prostate biopsies. One senior (reader 1) and one junior (reader 2) nuclear medicine physician evaluated each TZ lesion independently, according to the molecular imaging prostate-specific membrane antigen scoring system and the Prostate Imaging Reporting and Data System version 2.1 (PI-RADS v2.1). The histologic diagnosis of prostate biopsy was used as the reference standard. The diagnostic performance of the two methods was compared in terms of inter-reader agreement and area under the receiver operating characteristic (AUC-ROC) curve.
Of the 52 patients, 43 had TZ PCa. For inter-reader agreement, the kappa value was 0.883 for F-DCFPyL PET and 0.393 for mp-MRI. For PET, both readers had the same diagnostic sensitivity, specificity, and accuracy of 93.0%, 77.8%, and 90.4%, respectively. For mp-MRI, the diagnostic sensitivity, specificity, and accuracy was 67.4%, 33.3%, and 61.5% for reader 1, and 51.2%, 44.4%, and 51.9% for reader 2, respectively. PET outperformed mp-MRI for both readers with an AUC of 0.872 for PET versus 0.584 for mp-MRI, p = .0209 for reader 1, and an AUC of 0.860 for PET versus 0.505 for mp-MRI, p = .0213 for reader 2. Among the 43 patients with TZ PCa, F-DCFPyL PET detected a distant bone metastasis missed by the CT in one case and two small lymph node metastases missed by the CT and MRI in another case.
These results suggest that F-DCFPyL PET, which was almost independent of the experience of the readers, was more objective in the evaluation of TZ lesions, and had higher diagnostic value than mp-MRI.
我们旨在比较F-DCFPyL正电子发射断层扫描(PET)和多参数磁共振成像(mp-MRI)在检测移行区(TZ)前列腺癌(PCa)方面的诊断性能。
这项回顾性研究纳入了2019年1月至2020年6月期间接受F-DCFPyL PET/MRI检查的20例患者以及接受F-DCFPyL PET/CT和MRI检查的32例患者。所有患者均有TZ病变并接受了前列腺活检。一名资深核医学医师(读者1)和一名初级核医学医师(读者2)根据分子成像前列腺特异性膜抗原评分系统和前列腺影像报告与数据系统第2.1版(PI-RADS v2.1)独立评估每个TZ病变。前列腺活检的组织学诊断用作参考标准。从读者间一致性和受试者操作特征曲线下面积(AUC-ROC)方面比较了两种方法的诊断性能。
在这52例患者中,43例患有TZ PCa。关于读者间一致性,F-DCFPyL PET的kappa值为0.883,mp-MRI的kappa值为0.393。对于PET,两位读者的诊断敏感性、特异性和准确性分别相同,均为93.0%、77.8%和90.4%。对于mp-MRI,读者1的诊断敏感性、特异性和准确性分别为67.4%、33.3%和61.5%,读者2的分别为51.2%、44.4%和51.9%。对于两位读者而言,PET的表现均优于mp-MRI,PET的AUC为0.872,而mp-MRI的为0.584,读者1的p = 0.0209;PET的AUC为0.860,而mp-MRI的为0.505,读者2的p = 0.0213。在43例患有TZ PCa的患者中,F-DCFPyL PET检测到1例CT漏诊的远处骨转移以及另1例CT和MRI漏诊的2个小淋巴结转移。
这些结果表明,F-DCFPyL PET在评估TZ病变方面更客观,几乎不受读者经验的影响,并且比mp-MRI具有更高的诊断价值。